USPTO serial 87976728
THERANOVA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Mar 6, 2018
- Examiner
- MULLEN, MARK
- Law office
- Historical data usage
What this means
Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.
Need help with THERANOVA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
San Francisco, CA
San Francisco, CA
San Francisco, CA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donald A. Thompson
Donald A. Thompson THOMPSON & CO.595 Pacific Ave., 4th FloorSan Francisco, CA 94133United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 035 | Business consulting services in the field of medical devices; Business consulting and management in the field of clinical trials concerning medical devices, namely, providing information management services; Business consulting services in the field of regulatory approvals concerning medical devices; Providing consulting services in the field of regulatory submission management to medical companies to assist them with applications for medical device approval; Business consulting services in the field of regulatory submissions concerning medical devices; Business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for medical device approval; Business consulting and management in the field of clinical trials concerning medical devices, namely, providing information management services; Business consulting services in the field of quality system information management concerning medical devices; Regulatory submission management, namely, assisting others in preparing and filing applications for medical devices with governmental regulatory bodies; in each case, except in connection with dialysis | ACTIVE | Dec 31, 2005 |
| 042 | Consulting services in the field of medical device product development; Consulting services, namely, product testing, product safety testing and product quality testing consultation in the field of experimental tests concerning medical devices; Consulting services regarding the conducting of clinical trials for others relating to medical devices in the field of physical pain, cardiovascular disease, diabetes, osteoporosis, [ dementia, ] incontinence, overactive bladder, vascular access, body fluid drainage, and enteral feeding and monitoring; New product design, engineering, research, development services for others in the field of medical devices; in each case, except in the field of dialysis | ACTIVE | Dec 31, 2005 |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Oct 23, 2024 | NA85 | NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED | — |
| Oct 23, 2024 | C15A | REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK. | — |
| Oct 23, 2024 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Apr 29, 2024 | E815 | TEAS SECTION 8 & 15 RECEIVED | — |
| Mar 6, 2023 | REM1 | COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED | — |
| Nov 22, 2019 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 22, 2019 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Mar 6, 2018 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Jan 31, 2018 | SUNA | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | — |
| Jan 30, 2018 | CNPR | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | — |
| Jan 30, 2018 | SUPC | STATEMENT OF USE PROCESSING COMPLETE | — |
| Jan 30, 2018 | DPCC | DIVISIONAL PROCESSING COMPLETE | — |
| Jan 29, 2018 | AITU | CASE ASSIGNED TO INTENT TO USE PARALEGAL | — |
| Jan 17, 2018 | IUAF | USE AMENDMENT FILED | — |
| Jan 17, 2018 | DRRR | DIVISIONAL REQUEST RECEIVED | — |
| Jan 17, 2018 | ERTD | TEAS REQUEST TO DIVIDE RECEIVED | — |
| Jan 17, 2018 | EISU | TEAS STATEMENT OF USE RECEIVED | The applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action. |
| Aug 1, 2017 | NOAM | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| Jun 6, 2017 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Jun 6, 2017 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| May 17, 2017 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Apr 25, 2017 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 29, 2017 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 28, 2017 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 28, 2017 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2017 | ARAA | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Feb 27, 2017 | REAP | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED | — |
| Jan 9, 2017 | DOCK | ASSIGNED TO EXAMINER | — |
| Oct 6, 2016 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2016 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Oct 6, 2016 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 29, 2016 | DOCK | ASSIGNED TO EXAMINER | — |
| Jun 30, 2016 | MPMK | NOTICE OF PSEUDO MARK E-MAILED | — |
| Jun 29, 2016 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jun 27, 2016 | NWAP | NEW APPLICATION ENTERED | — |